巴拉特生物技术的争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 1 条
2021
巴西因相关指控暂时中止Covaxin合同
问题披露
巴西卫生部宣布暂时中止Covaxin合同，相关疫苗交易受到可能存在腐败及不规范行为的指控。Bharat Biotech否认疫苗供应方面存在不当行为。
品牌回应
否认 — Bharat Biotech
Bharat Biotech has denied any allegation of wrongdoing with respect to vaccine supply.
来源摘录
The Health Ministry official said he faced pressure to greenlight the import of Indian pharmaceutical Bharat Biotech's Covaxin vaccine and that there were irregularities in the invoices — particularly a $45 million upfront payment to a Singapore-based company.
Brazil health ministry on Tuesday announced that the government is “temporarily suspending” the Covaxin contract even as President Jair Bolsonaro is under fire for possible corruption in the vaccine deal